Actively Recruiting
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Led by California Pacific Medical Center Research Institute · Updated on 2026-03-23
8000
Participants Needed
1
Research Sites
1013 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
CONDITIONS
Official Title
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients age >18 years that have been referred for endoscopic treatment of GI lesions.
You will not qualify if you...
- Patients for whom endoscopic treatment was not performed.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Interventional Endoscopy Services
San Francisco, California, United States, 94115
Actively Recruiting
Research Team
J
Jona C Bernabe
CONTACT
H
Hayden Sampson
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here